{"product_id":"harvard-gastroenterology-2025","title":"Harvard Gastroenterology 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: gastroenterologists, internists, surgeons\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe Comprehensive 2025 Gastroenterology Update\u003c\/p\u003e\n\u003cp\u003eGastroenterology 2025 will be held online this year, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies.\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eThis program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.\u003c\/p\u003e\n\u003cp\u003ePractical, Results-Driven Education\u003c\/p\u003e\n\u003ch3\u003eHighlights of the 2025 program include:\u003c\/h3\u003e\n\u003cp\u003eThe newest guidelines for the use of biologics in IBD\u003c\/p\u003e\n\u003cp\u003eTherapeutic drug monitoring in IBD treatment\u003c\/p\u003e\n\u003cp\u003eManagement of the older adult with IBD\u003c\/p\u003e\n\u003cp\u003eUpdated guidelines for treatment of C. difficile infection\u003c\/p\u003e\n\u003cp\u003eManaging GI complications of immunotherapy and anti-neoplastic therapies\u003c\/p\u003e\n\u003cp\u003eImproved management of IBS\u003c\/p\u003e\n\u003cp\u003eTips for managing fecal incontinence\u003c\/p\u003e\n\u003cp\u003eManagement of refractory GERD\u003c\/p\u003e\n\u003cp\u003eExpanded genetic testing options to diagnose hereditary GI cancer syndromes\u003c\/p\u003e\n\u003cp\u003eUpdated treatment of HBV and HCV\u003c\/p\u003e\n\u003cp\u003eManagement of steatotic liver disease in 2025\u003c\/p\u003e\n\u003cp\u003eHow to diagnose and manage cirrhosis\u003c\/p\u003e\n\u003cp\u003eHow to improve your adenoma detection rate (ADR)\u003c\/p\u003e\n\u003cp\u003eSteps to ensure delivery of high-quality colonoscopic care\u003c\/p\u003e\n\u003cp\u003eTechniques to effectively control acute GI bleeding\u003c\/p\u003e\n\u003cp\u003eEndoscopic management of obesity\u003c\/p\u003e\n\u003cp\u003eWhen FMT is indicated for treatment\u003c\/p\u003e\n\u003cp\u003eNew strategies to treat common GI problems\u003c\/p\u003e\n\u003cp\u003eA comprehensive update of national guidelines\u003c\/p\u003e\n\u003cp\u003eEducation to Optimize Your Patient Outcomes\u003c\/p\u003e\n\u003ch3\u003eThe evidence-based recommendations provided in this program cover:\u003c\/h3\u003e\n\u003cp\u003eIBD\u003c\/p\u003e\n\u003cp\u003eGI Complications of Immunotherapy\u003c\/p\u003e\n\u003cp\u003eMicroscopic Colitis\u003c\/p\u003e\n\u003cp\u003eSteatotic Liver\u003c\/p\u003e\n\u003cp\u003eBarrett’s Esophagus\u003c\/p\u003e\n\u003cp\u003eEosinophilic Esophagitis\u003c\/p\u003e\n\u003cp\u003eC. difficile Colitis\u003c\/p\u003e\n\u003cp\u003eAlcohol-Related Liver Disease\u003c\/p\u003e\n\u003cp\u003eAutoimmune Hepatitis\u003c\/p\u003e\n\u003cp\u003eIBS\u003c\/p\u003e\n\u003cp\u003eRefractory GERD\u003c\/p\u003e\n\u003cp\u003eAcute Pancreatitis\u003c\/p\u003e\n\u003cp\u003eChronic Pancreatitis\u003c\/p\u003e\n\u003cp\u003eCeliac Disease\u003c\/p\u003e\n\u003cp\u003eGI Bleeding\u003c\/p\u003e\n\u003cp\u003eHigh Risk for Colorectal Cancer\u003c\/p\u003e\n\u003cp\u003eRecent Advances and Innovations\u003c\/p\u003e\n\u003ch3\u003eClinicians can rely on this program for education on:\u003c\/h3\u003e\n\u003cp\u003eBiological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?\u003c\/p\u003e\n\u003cp\u003eGI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?\u003c\/p\u003e\n\u003cp\u003eEosinophilic esophagitis: how to decide between drug therapy and dietary therapy?\u003c\/p\u003e\n\u003cp\u003eThe stool microbiome: understanding the science behind clinical applications\u003c\/p\u003e\n\u003cp\u003eCeliac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon\u003c\/p\u003e\n\u003cp\u003eAdenoma detection rates: critical to measure and how to incorporate strategies, including AI, to increase your rate\u003c\/p\u003e\n\u003cp\u003eEndoscopic approaches to managing obesity\u003c\/p\u003e\n\u003cp\u003eUpdated treatments for HBV and HCV\u003c\/p\u003e\n\u003cp\u003eThis program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics.\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eGastroenterologists\u003c\/p\u003e\n\u003cp\u003eInternists\u003c\/p\u003e\n\u003cp\u003eSurgeons\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMonday, June 9, 2025\u003c\/p\u003e\n\u003cp\u003e8:25am to 8:30am\u003c\/p\u003e\n\u003cp\u003eWelcome\u003c\/p\u003e\n\u003cp\u003eDaniel Chung, MD\u003c\/p\u003e\n\u003cp\u003e8:30am to 9:10am\u003c\/p\u003e\n\u003cp\u003eWhich Initial Therapy to Choose in Crohn’s Disease?\u003c\/p\u003e\n\u003cp\u003eJoshua Korzenik, MD\u003c\/p\u003e\n\u003cp\u003e9:10am to 9:50am\u003c\/p\u003e\n\u003cp\u003eWhich Initial Therapy to Choose in Ulcerative Colitis?\u003c\/p\u003e\n\u003cp\u003eAshwin Ananthakrishnan, MD, MPH\u003c\/p\u003e\n\u003cp\u003e9:50am to 10:20am\u003c\/p\u003e\n\u003cp\u003ePutting It Together: Illustrative IBD Case Presentations\u003c\/p\u003e\n\u003cp\u003eKristin Burke, MD, MPH\u003c\/p\u003e\n\u003cp\u003e10:20am to 10:35am\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Ananthakrishnan, Burke, and Korzenik\u003c\/p\u003e\n\u003cp\u003e10:35am to 10:50am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e10:50am to 11:15am\u003c\/p\u003e\n\u003cp\u003eManagement of the Older Adult with IBD\u003c\/p\u003e\n\u003cp\u003eBharati Kochar, MD, MS\u003c\/p\u003e\n\u003cp\u003e11:15am to 11:40am\u003c\/p\u003e\n\u003cp\u003eIBD in Pregnancy\u003c\/p\u003e\n\u003cp\u003eLoren Rabinowitz, MD\u003c\/p\u003e\n\u003cp\u003e11:40am to 12:15pm\u003c\/p\u003e\n\u003cp\u003eTherapeutic Drug Monitoring in IBD\u003c\/p\u003e\n\u003cp\u003eAdam Cheifetz, MD\u003c\/p\u003e\n\u003cp\u003e12:15pm to 12:30pm\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Cheifetz, Kochar, and Rabinowitz\u003c\/p\u003e\n\u003cp\u003e12:30pm to 1:30pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e1:30pm to 2:00pm\u003c\/p\u003e\n\u003cp\u003eHow to Manage Microscopic Colitis\u003c\/p\u003e\n\u003cp\u003eHamed Khalili, MD, MPH\u003c\/p\u003e\n\u003cp\u003e2:00pm to 2:30pm\u003c\/p\u003e\n\u003cp\u003eGI Complications of Immunotherapy\u003c\/p\u003e\n\u003cp\u003eMichael Dougan, MD, PhD\u003c\/p\u003e\n\u003cp\u003e2:30pm to 3:00pm\u003c\/p\u003e\n\u003cp\u003eGI Complications of Antineoplastic Therapy\u003c\/p\u003e\n\u003cp\u003eShilpa Grover, MBBS, MPH\u003c\/p\u003e\n\u003cp\u003e3:00pm to 3:15pm\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Dougan, Grover, and Khalili\u003c\/p\u003e\n\u003cp\u003e3:15pm to 3:30pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e3:30pm to 4:00pm\u003c\/p\u003e\n\u003cp\u003eGenetic Testing for Hereditary GI Cancer Syndromes\u003c\/p\u003e\n\u003cp\u003eDaniel Chung, MD\u003c\/p\u003e\n\u003cp\u003e4:00pm to 4:30pm\u003c\/p\u003e\n\u003cp\u003eCRC Screening and How to Improve Your ADR\u003c\/p\u003e\n\u003cp\u003eRamona Lim, MD\u003c\/p\u003e\n\u003cp\u003e4:30pm to 5:00pm\u003c\/p\u003e\n\u003cp\u003eBeyond Screening: What to Recommend to Reduce Colorectal Cancer Risk\u003c\/p\u003e\n\u003cp\u003eAndrew Chan, MD, MPH\u003c\/p\u003e\n\u003cp\u003e5:00pm to 5:15pm\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Chan, Chung, and Lim\u003c\/p\u003e\n\u003cp\u003eTuesday, June 10, 2025\u003c\/p\u003e\n\u003cp\u003e8:30am to 9:10am\u003c\/p\u003e\n\u003cp\u003eBarrett’s Esophagus: Whom and How to Treat?\u003c\/p\u003e\n\u003cp\u003eDouglas Pleskow, MD\u003c\/p\u003e\n\u003cp\u003e9:10am to 9:40am\u003c\/p\u003e\n\u003cp\u003eEsophageal Motility Disorders Made Easy\u003c\/p\u003e\n\u003cp\u003eBarbara Nath, MD\u003c\/p\u003e\n\u003cp\u003e9:40am to 10:10am\u003c\/p\u003e\n\u003cp\u003eManagement of Refractory GERD\u003c\/p\u003e\n\u003cp\u003eNorman Nishioka, MD\u003c\/p\u003e\n\u003cp\u003e10:10am to 10:25am\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Nath, Nishioka, and Pleskow\u003c\/p\u003e\n\u003cp\u003e10:25am to 10:40am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e10:40am to 11:20am\u003c\/p\u003e\n\u003cp\u003eComprehensive Approach to Eosinophilic Esophagitis\u003c\/p\u003e\n\u003cp\u003eWalter Chan, MD, MPH\u003c\/p\u003e\n\u003cp\u003e11:20am to 12:05pm\u003c\/p\u003e\n\u003cp\u003eCeliac Disease and Gluten Sensitivity: 2025 Practitioner Updates\u003c\/p\u003e\n\u003cp\u003eCiaran Kelly, MD\u003c\/p\u003e\n\u003cp\u003e12:05pm to 12:20pm\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDr. Chan\u003c\/p\u003e\n\u003cp\u003e12:20pm to 1:30pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e1:30pm to 2:00pm\u003c\/p\u003e\n\u003cp\u003eMaking the Diagnosis of IBS\u003c\/p\u003e\n\u003cp\u003eKyle Staller, MD\u003c\/p\u003e\n\u003cp\u003e2:00pm to 2:30pm\u003c\/p\u003e\n\u003cp\u003eModern Strategies to Treat IBS\u003c\/p\u003e\n\u003cp\u003eVikram Rangan, MD\u003c\/p\u003e\n\u003cp\u003e2:30pm to 2:50pm\u003c\/p\u003e\n\u003cp\u003eTips for Managing Fecal Incontinence\u003c\/p\u003e\n\u003cp\u003eKyle Staller, MD\u003c\/p\u003e\n\u003cp\u003e2:50pm to 3:05pm\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Kelly, Rangan, and Staller\u003c\/p\u003e\n\u003cp\u003e3:05pm to 3:25pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e3:25pm to 4:05pm\u003c\/p\u003e\n\u003cp\u003eOptimizing the Management of Gastroparesis\u003c\/p\u003e\n\u003cp\u003eBraden Kuo, MD\u003c\/p\u003e\n\u003cp\u003e4:05pm to 4:35pm\u003c\/p\u003e\n\u003cp\u003eHow to Evaluate Small Intestinal Bacterial Overgrowth\u003c\/p\u003e\n\u003cp\u003eJudy Nee, MD\u003c\/p\u003e\n\u003cp\u003e4:35pm to 4:50pm\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Kuo and Nee\u003c\/p\u003e\n\u003cp\u003eWednesday, June 11, 2025\u003c\/p\u003e\n\u003cp\u003e8:30am to 9:00am\u003c\/p\u003e\n\u003cp\u003eCholestatic Liver Diseases: What’s New in PBC and PSC\u003c\/p\u003e\n\u003cp\u003eDaniel Pratt, MD\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:30am\u003c\/p\u003e\n\u003cp\u003eHow to Manage Autoimmune Hepatitis\u003c\/p\u003e\n\u003cp\u003eAlan Bonder, MD\u003c\/p\u003e\n\u003cp\u003e9:30am to 10:05am\u003c\/p\u003e\n\u003cp\u003eUpdates in the Treatment of HBV and HCV\u003c\/p\u003e\n\u003cp\u003eMichael Curry, MD\u003c\/p\u003e\n\u003cp\u003e10:05am to 10:20am\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Bonder, Curry, and Pratt\u003c\/p\u003e\n\u003cp\u003e10:20am to 10:35am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e10:35am to 11:15am\u003c\/p\u003e\n\u003cp\u003eAlcohol-Associated Liver Disease\u003c\/p\u003e\n\u003cp\u003eGyongyi Szabo, MD, PhD\u003c\/p\u003e\n\u003cp\u003e11:15am to 11:45am\u003c\/p\u003e\n\u003cp\u003eThe Management of MASLD\u003c\/p\u003e\n\u003cp\u003eKathleen Corey, MD\u003c\/p\u003e\n\u003cp\u003e11:45am to 12:00pm\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Corey and Szabo\u003c\/p\u003e\n\u003cp\u003e12:00pm to 1:00pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e1:00pm to 1:30pm\u003c\/p\u003e\n\u003cp\u003eHow to Work Up a Liver Lesion\u003c\/p\u003e\n\u003cp\u003eKarin Andersson, MD, MPH\u003c\/p\u003e\n\u003cp\u003e1:30pm to 2:00pm\u003c\/p\u003e\n\u003cp\u003eDiagnosis and Routine Management of Cirrhosis\u003c\/p\u003e\n\u003cp\u003eMichelle Lai, MD\u003c\/p\u003e\n\u003cp\u003e2:00pm to 2:40pm\u003c\/p\u003e\n\u003cp\u003eEnd-Stage Liver Disease and Management of Portal Hypertension\u003c\/p\u003e\n\u003cp\u003eAnna Rutherford, MD, MPH\u003c\/p\u003e\n\u003cp\u003e2:40pm to 3:00pm\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Andersson, Lai, and Rutherford\u003c\/p\u003e\n\u003cp\u003e3:00pm to 3:15pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e3:15pm to 3:50pm\u003c\/p\u003e\n\u003cp\u003eBest Management Strategies in Acute Pancreatitis\u003c\/p\u003e\n\u003cp\u003eDavid Jin, MD, MPH\u003c\/p\u003e\n\u003cp\u003e3:50pm to 4:25pm\u003c\/p\u003e\n\u003cp\u003eUpdates in Chronic Pancreatitis\u003c\/p\u003e\n\u003cp\u003eSunil Sheth, MD\u003c\/p\u003e\n\u003cp\u003e4:25pm to 4:55pm\u003c\/p\u003e\n\u003cp\u003eControversies in the Management of Cystic Lesions of the Pancreas\u003c\/p\u003e\n\u003cp\u003eCarlos Fernandez-del Castillo, MD\u003c\/p\u003e\n\u003cp\u003e4:55pm to 5:10pm\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Fernandez-del Castillo, Jin, and Sheth\u003c\/p\u003e\n\u003cp\u003eThursday, June 12, 2025\u003c\/p\u003e\n\u003cp\u003e8:30am to 9:10am\u003c\/p\u003e\n\u003cp\u003eTips for Removing the Difficult Colon Polyp\u003c\/p\u003e\n\u003cp\u003eTyler Berzin, MD\u003c\/p\u003e\n\u003cp\u003e9:10am to 9:40am\u003c\/p\u003e\n\u003cp\u003eQuality Measures for Colonoscopy: What’s New and Why It Matters\u003c\/p\u003e\n\u003cp\u003eMandeep Sawhney, MD\u003c\/p\u003e\n\u003cp\u003e9:40am to 10:10am\u003c\/p\u003e\n\u003cp\u003eEndoscopy and the Anticoagulated Patient\u003c\/p\u003e\n\u003cp\u003eKunal Jajoo, MD\u003c\/p\u003e\n\u003cp\u003e10:10am to 10:25am\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Berzin, Jajoo, and Sawhney\u003c\/p\u003e\n\u003cp\u003e10:25am to 10:40am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e10:40am to 11:20am\u003c\/p\u003e\n\u003cp\u003eAcute GI Bleeding and Other GI Emergencies\u003c\/p\u003e\n\u003cp\u003eLinda Lee, MD\u003c\/p\u003e\n\u003cp\u003e11:20am to 11:50am\u003c\/p\u003e\n\u003cp\u003eAdvances in Endoscopic Surgery for Foregut Disorders\u003c\/p\u003e\n\u003cp\u003eKumar Krishnan, MD\u003c\/p\u003e\n\u003cp\u003e11:50am to 12:20pm\u003c\/p\u003e\n\u003cp\u003eEndoscopic Approaches to Manage Obesity\u003c\/p\u003e\n\u003cp\u003eChristopher Thompson, MD\u003c\/p\u003e\n\u003cp\u003e12:20pm to 12:35pm\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Krishnan, Lee, and Thompson\u003c\/p\u003e\n\u003cp\u003e12:35pm to 1:45pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e1:45pm to 2:25pm\u003c\/p\u003e\n\u003cp\u003eWhat’s New in C. difficile Colitis\u003c\/p\u003e\n\u003cp\u003eJessica Allegretti, MD, MPH\u003c\/p\u003e\n\u003cp\u003e2:25pm to 2:55pm\u003c\/p\u003e\n\u003cp\u003eNew Insights into the Gut Microbiome and Disease\u003c\/p\u003e\n\u003cp\u003eRamnik Xavier, MD\u003c\/p\u003e\n\u003cp\u003e2:55pm to 3:25pm\u003c\/p\u003e\n\u003cp\u003eGI Cases to Remember\u003c\/p\u003e\n\u003cp\u003eDouglas Horst, MD\u003c\/p\u003e\n\u003cp\u003e3:25pm to 3:40pm\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDrs. Allegretti, Horst, and Xavier\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405766611140,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Gastroenterology-2025.jpg?v=1784215860","url":"https:\/\/medicalcoursespro.com\/products\/harvard-gastroenterology-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}